Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries [PDF]
, 2009 BACKGROUND: In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated.
Arnaud Fontanet +33 more
core +3 more sources
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
Nature Communications, 2018 The efficacy of antiretroviral therapy is significantly compromised by medication non-adherence. Long-acting enteral systems that can ease the burden of daily adherence have not yet been developed.
Ameya R. Kirtane +24 more
semanticscholar +1 more source
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration [PDF]
, 2011 Article approval pendingWith expanding pediatric antiretroviral therapy (ART) access, children will begin to experience treatment failure and require second-line therapy. We evaluated the probability and determinants of virologic failure and switching in
Boulle, Andrew +10 more
core +2 more sources
Optimizing resources to reduce costs to determine HIV viral load in limited resources settings
Biomédica: revista del Instituto Nacional de Salud, 2017 Introduction: HIV viral load testing is a key factor to evaluate the accomplishment of the UNAIDS target of 90% of viral suppression among people receiving antiretroviral therapy.
Amalia Girón-Callejas +4 more
doaj +1 more source
Journal of the International AIDS Society, 2018 Optimal adherence to antiretroviral therapy is closely related with suppression of the HIV viral load in plasma, slowing disease progression and decreasing HIV transmission rates. Despite its importance, the estimated proportion of people living with HIV
J. Costa, T. Torres, L. Coelho, P. Luz
semanticscholar +1 more source
Factors of Loss to Follow-up Antiretroviral Therapy in Islanded Area
Unnes Journal of Public Health, 2018 Loss to follow-up of antiretroviral therapy is when PLWHA (People Living with HIV/AIDS) do not come for antiretroviral therapy for more than 3 months. This study aimed to determine the factors of loss to follow-up antiretroviral therapy for PLWHA at Prof.
Thomas Laga Boro +2 more
doaj +1 more source
Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. [PDF]
PLoS ONE, 2013 Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of ...
Hannock Tweya +11 more
doaj +1 more source
Incidence and risk factors for tuberculosis among people living with HIV in Bangui: A cohort study
Public Health in Practice, 2022 Objectives: The objectives of this study were to determine the incidence and risk factors of tuberculosis (TB) among people living with HIV (PLHIV). Methods: A cohort study was carried out in an HIV infection management centre in Bangui. PLHIV aged 18 or
Jean De Dieu Longo +5 more
doaj
Canadian Medical Association Journal, 2018 Background: The Public Health Agency of Canada reviewed sexual transmission of HIV between serodiscordant partners to support examination of the criminal justice system response to HIV nondisclosure by the Department of Justice of Canada.
J. Lemessurier +8 more
semanticscholar +1 more source
SAGE Open Medicine, 2019 Objective: To determine the survival rate and predictors of HIV-infected children on antiretroviral therapy at two selected facilities in North Ethiopia.
Getachew Arage +3 more
doaj +1 more source